HIGHLIGHTS
- who: Honghong, Ma and Yanmei, Ma from the Department of Cardiovascular Medicine, The First Hospital of Yulin, Yulin, Shaanxi, China have published the research: Dapagliflozin Inhibits Ventricular Remodeling in Heart Failure Rats by Activating Autophagy through AMPK/mTOR Pathway, in the Journal: Computational and Mathematical Methods in Medicine of 23/09/2022
- what: The authors aimed to clarify DAPA impact on cellular behaviors in_vitro. These finding suggested that DAPA hinders left VR and benefits cardiac function in HF progression, which was in line with the study proposed by Zhang et_al They have demonstrated that DAPA . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.